Benjamin G. Vincent
Affiliations: | Department of Microbiology and Immunology | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Website:
https://unclineberger.org/directory/benjamin-vincent/Google:
"Benjamin Vincent"Parents
Sign in to add mentor| Jeffrey A. Frelinger | post-doc | UNC Chapel Hill (Microtree) | ||
| (Med-Fellow) | ||||
Children
Sign in to add trainee| Christof C. Smith | grad student | 2020 | UNC Chapel Hill |
| Kelly S. Olsen | grad student | 2023 | UNC Chapel Hill |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Routh ED, Woodcock MG, Beckabir W, et al. (2023) Evaluation of tumor antigen-specific antibody responses in patients with metastatic triple negative breast cancer treated with cyclophosphamide and pembrolizumab. Journal For Immunotherapy of Cancer. 11 |
| Olsen KS, Jadi O, Dexheimer S, et al. (2022) Shared graft-vs-leukemia minor histocompatibility antigens in DISCOVeRY-BMT. Blood Advances |
| Li S, Mirlekar B, Johnson BM, et al. (2022) STING-induced regulatory B cells compromise NK function in cancer immunity. Nature |
| Mirlekar B, Wang Y, Li S, et al. (2022) Balance between immunoregulatory B cells and plasma cells drives pancreatic tumor immunity. Cell Reports. Medicine. 3: 100744 |
| Chai S, Smith CC, Kochar TK, et al. (2022) NeoSplice: a bioinformatics method for prediction of splice variant neoantigens. Bioinformatics Advances. 2: vbac032 |
| Nishijima TF, Kardos J, Chai S, et al. (2022) Molecular and Clinical Characterization of a Claudin-Low Subtype of Gastric Cancer. Jco Precision Oncology. 1: 1-10 |
| Anders CK, Woodcock MG, Van Swearingen AED, et al. (2022) Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer. Journal For Immunotherapy of Cancer. 10 |
| Downs-Canner SM, Meier J, Vincent BG, et al. (2022) B Cell Function in the Tumor Microenvironment. Annual Review of Immunology |
| Zeidner JF, Vincent BG, Ivanova A, et al. (2021) Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia. Blood Cancer Discovery. 2: 616-629 |
| Tschernia NP, Kumar V, Moore DT, et al. (2021) Safety and efficacy of pembrolizumab prior to allogeneic stem cell transplant in Acute Myeloid Leukemia. Transplantation and Cellular Therapy |